$30 Million available via Pharmaceutical Benefit Plan Settlements
Overview
There are typically several active lawsuits and/or class action settlements that fall into the category of “pharmaceutical benefit plan settlements.” Under these cases, it is generally alleged that businesses with self-insured health plans overpaid for drugs purchased on behalf of their employees due to artificially inflated and/or stabilized prices.
The prices were allegedly manipulated as a result of anti-competitive practices undertaken by the drug manufacturers. The number of these opportunities in any given year varies, but there can be several available at the same time.
Immediately Available Settlement(s):
Suboxone Settlement
Date Range: December 2011 - August 2023
Settlement Fund: $30 million
Filing Deadline: 2/17/2024
Settlement Overview: This settlement resolves allegations the Defendant violated antitrust laws in the United States, harming competition and preventing class members from choosing lower-priced generic versions of Suboxone (a prescription drug used to treat opioid dependence).
Eligible Locations: To be a member of the Settlement Class, you must have indirectly purchased, paid and/or provided reimbursement for some or all of the purchase price of Co-Formulated Buprenorphine/Naloxone (Suboxone and/or its AB-rated generic equivalent) in any form, in Select States.
Select States: Alabama, Arizona, California, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, Puerto Rico, Rhode Island, South Dakota, Tennessee, Utah, Vermont, Virginia, West Virginia, and Wisconsin.
Eligible Drugs: Co‐Formulated Buprenorphine/Naloxone (Suboxone and/or its AB‐rated generic equivalent) in any form.
Recommended Next Steps Data is often required to complete your claim for settlements in this category. Connect us with a member of your Benefits Department so an MCAG representative can describe the information that is necessary to complete your claim for these pharmaceutical settlements. We typically only need a 5 to 10 minute call. We will quickly review the process so we can efficiently obtain necessary information from your Pharmacy Benefit Manager (i.e. CVS Caremark, Express Scripts, OptumRX) to pursue current and future pharmaceutical settlements.
Eligible contracted clients can expect to be contacted by an MCAG representative to review and assist with gathering the necessary information for these settlements.
MCAG is not the Settlement/Class Administrator, and this is not an official settlement website.
Need more information? CLICK HERE to complete our contact form and an MCAG representative will respond shortly.